Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;11(3):403-408.
doi: 10.1007/s41999-020-00289-z. Epub 2020 Jan 31.

Bone metabolic biomarkers and bone mineral density in male patients with early-stage Alzheimer's disease

Zhengping Pu #  1 , Xiaoqing Tang #  2 , Yu'e Fei  3 , Qingmei Hou  4 , Yong Lin  1 , Xianyou Zha  1
Affiliations

Bone metabolic biomarkers and bone mineral density in male patients with early-stage Alzheimer's disease

Zhengping Pu et al. Eur Geriatr Med. 2020 Jun.

Abstract

Purpose: Alzheimer's disease (AD), osteoporosis, and osteopenia are the most common diseases in older individuals and share some similar pathophysiological processes of degeneration. The aim of this study is to investigate the association between bone metabolic biomarkers, bone mineral density (BMD), and early-stage AD in men.

Methods: Forty-two male early-stage AD patients and 40 age-matched healthy older volunteers were enrolled. Serum calcium, osteocalcin, 1,25(OH)2D3, urine deoxypyridinoline/creatinine (DPD/Cr) ratio, urine calcium/creatinine (Ca/Cr) ratio, and BMD were measured. The correlation between early-stage AD and bone quality was evaluated.

Results: The urine DPD/Cr, urine Ca/Cr, and serum osteocalcin levels in the early-stage AD patients were significantly higher than those in the healthy control (HC) group (P < 0.05). The BMD data showed that the cortical and total BMD at 38% of the tibial length in the early-stage AD patients were lower than those in the HC group (P < 0.05). Furthermore, there was a negative correlation between the Montreal Cognitive Assessment score and serum osteocalcin or urine DPD/Cr levels. Abnormal urine DPD/Cr, urine Ca/Cr, and cortical BMD levels were independent risk factors in male patients with early-stage AD.

Conclusion: Bone metabolic biomarkers and BMD are closely associated with early-stage AD in male patients. Our data indicated that the measurement of bone metabolic biomarkers and BMD may provide an alternative approach for screening AD patients at the early stage.

Keywords: Alzheimer’s disease; Bone metabolism; Bone mineral density; Osteoporosis.

PubMed Disclaimer

References

    1. Rathbone CJ, Ellis JA, Ahmed S, Moulin CJA, Ernst A, Butler CR (2019) Using memories to support the self in Alzheimer’s disease. Cortex 121:332–346 - DOI
    1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9(63–75):e2
    1. Wang JH, Wu YJ, Tee BL, Lo RY (2018) Medical comorbidity in Alzheimer’s disease: a nested case–control study. J Alzheimers Dis 63:773–781 - DOI
    1. Downey CL, Young A, Burton EF, Graham SM, Macfarlane RJ, Tsapakis EM et al (2017) Dementia and osteoporosis in a geriatric population: is there a common link? World J Orthop 8:412–423 - DOI
    1. Laudisio A, Fontana DO, Rivera C, Ruggiero C, Bandinelli S, Gemma A et al (2016) Bone mineral density and cognitive decline in elderly women: results from the InCHIANTI study. Calcif Tissue Int 98:479–488 - DOI

Publication types

LinkOut - more resources